Testing a device to help chronic left heart failure
Part of Heart & circulation clinical trials.
This trial studies a small implant (an “atrial shunt” device) to improve symptoms and heart function in people with chronic left heart failure that stays active despite standard medicines. It focuses on whether the implant is safe and can help you feel better and possibly breathe easier.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- Your heart failure symptoms have been present for at least 1 month despite stable standard medicines
- You were hospitalized for heart failure within the last 12 months
- Your heart pressure measurements (from a heart catheter) show fluid backup in the lungs/left side of the heart (specific thresholds)
- Your symptoms are moderate to severe (NYHA class II to IV)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a small device that creates a tiny opening inside the heart to help lower pressure and improve symptoms in people with heart failure. The procedure is minimally invasive and aims to reduce hospitalizations and improve quality of life.
This trial tests a small device placed in the heart to help reduce fluid buildup and ease breathing in people with advanced heart failure. It might help you feel better and avoid hospital stays.
This trial tests a new device that creates a small shunt (passage) in the heart to help relieve pressure and improve symptoms in people with heart failure and a weak heart pump. The goal is to see if the device is safe and helpful for patients like you.
This trial studies a small device placed in the heart to create a passage that may help relieve pressure and improve symptoms in people with heart failure and a weak pumping function. It aims to see if the device is safe and helpful for daily life.
This trial studies whether the ContraBand device can be safely placed in people with long-term, symptomatic heart failure and reduced heart pumping. It also looks at whether the approach is practical and tolerable, and gathers early safety information.
This trial tests a wirelessly implanted device that measures pressure in the left upper heart chamber (left atrial pressure) in people with advanced heart failure. By tracking that pressure, researchers hope to better understand disease status and guide care.
Hear when a new Left Heart Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.